Related Experiment Videos
Results of chemotherapy in advanced carcinoma of the fallopian tube
W A Peters1, W A Andersen, M P Hopkins
1Puget Sound Oncology Consortium, Seattle, WA.
Cancer
|March 1, 1989
Abstract:
Forty-six patients with measurable disease received chemotherapy for advanced primary or recurrent carcinoma of the fallopian tube. The response rate was 9% with single-agent therapy, 29% with multiagent therapy without cisplatin, and 81% with cisplatin-containing combination therapy. Survival was significantly improved in Stage III/IV with the addition of cisplatin-based combination therapy.